Compaction of enteric-coated pellets: Influence of formulation and process parameters on tablet properties and in vivo evaluation

European Journal of Pharmaceutical Sciences

Volumn 22, Issue 4, 2004, Pages 305-314

  Debunne, Ann ^a   Vervaet, Chris ^a   Mangelings, Debby ^b   Remon, Jean Paul ^a  

^a GHENT UNIVERSITY   (Belgium)

^b PHARMACEUTICAL INSTITUTE   (Belgium)

Author keywords

Compaction; Enteric coating; In vivo evaluation; Pellets; Piroxicam

Indexed keywords

CARBOXYMETHYLCELLULOSE; EUDRAGIT; MICROCRYSTALLINE CELLULOSE; PIROXICAM; POLYMER; POVIDONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG COATING; DRUG DETERMINATION; DRUG SCREENING; ENTERIC COATED TABLET; EXPERIMENTAL DESIGN; FEMALE; IN VIVO STUDY; MALE; MULTIPLE DRUG DOSE; NONHUMAN; PARAMETER; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; PROCESS CONTROL; SINGLE DRUG DOSE; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET PROPERTY; VARIANCE;

CARBOXYMETHYLCELLULOSE; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; MICROSCOPY, ELECTRON, SCANNING; TABLETS; TABLETS, ENTERIC-COATED;

EID: 2942616956     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2004.03.017     Document Type: Article

References (25)

1. Aabakken L., Olaussen B., Mowinckel P., Osnes M. Gastroduodenal lesions associated with two different piroxicam formulations. An endoscopic evaluation. Scand. J. Gastroenterol. 27:1992;1049-1054
2. Aulton M.E., Dyer A.M., Khan K.A. The strength and compaction of millispheres: the design of a controlled-release drug delivery system for ibuprofen in the form of a tablet comprising compacted polymer-coated millispheres. Drug Dev. Ind. Pharm. 20:1994;3069-3104
3. Baert K., De Backer P. Disposition of sodium salicylate, flunixin and meloxicam after intravenous administration in broiler chickens. J. Vet. Pharmacol. Therap. 25:2002;449-453
4. Beckert T.E., Lehmann K., Schmidt P.C. Compression of enteric-coated pellets to disintegrating tablets. Int. J. Pharm. 143:1996;13-23
5. Bjarnasson I., Fehilly B., Smethurst P., Menzies I.S., Levi A.J. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut. 32:1991;275-277
6. Debunne A., Vervaet C., Remon J-P. Development and in vitro evaluation of an enteric-coated multiparticulate drug delivery system for the administration of piroxicam to dogs. Eur. J. Pharm. Biopharm. 54:2002;343-348
7. Felton L.A., Shah N.H., Zhang G., Infeld M.H., Malick A.W., McGinity J.W. Compaction properties of individual nonpareil beads coated with an acrylic resin copolymer. S.T.P. Pharm. Sci. 7:1997;457-462
8. Flament M-P., Leterme P., Gayot A., Gendrot E., Bruna E., Cousin G. Development and industrial scale-up of tablets containing modified-release pellets. Pharm. Tech. Eur. 6:1994;19-25
9. Galbraith E.A., McKellar Q.A. Pharmacokinetics and pharmacodynamics of piroxicam in dogs. Vet. Rec. 128:1991;561-565
10. Hussain M.A., Chang R-K., Sandefer E., Page R.C., Digenis G.A. Evaluation of the in vivo disintegration of a bile acid sequestrant in dogs using γ-scintigraphy and correlation to in vitro disintegration. Pharm. Res. 20:2003;460-464
11. Husson I., Leclerc B., Spenlehauer G., Veillard M., Puisieux F., Couarraze G. Influence of size polydispersity on drug release from coated pellets. Int. J. Pharm. 86:1992;113-121
12. Lehmann K., Petereit H.-U., Dreher D. Schnellzerfallende tabletten mit gesteuerter wirkstoffabgabe. Pharm. Ind. 55:1993;940-947
13. Lundqvist A.E.K., Podczeck F., Newton J.M. Influence of disintegrant type and proportion on the properties of tablets produced from mixtures of pellets. Int. J. Pharm. 147:1997;95-107
14. Lundqvist A.E.K., Podczeck F., Newton J.M. Compaction of, and drug release from, coated drug pellets mixed with other pellets. Eur. J. Pharm. Biopharm. 46:1998;369-379
15. McKellar Q.A., Carmichael S. Non-steroidal anti-inflammatory drugs in dogs. Association for Veterinary Clinical Pharmacology and Therapeutics. Proceedings. 13:1988;14-20
16. McKellar Q.A., May S.A., Lees P. Pharmacology and therapeutics of nonsteroidal anti inflammatory drugs in the dog and cat: 2 Individual agents. J. Small Anim. Pract. 32:1991;225-235
17. Pinto J.F., Podczeck F., Newton J.M. The use of a statistical moment analysis to elucidate the mechanism of release of a model drug from pellets produced by extrusion and spheronisation. Chem. Pharm. Bull. 45:1997;171-180
18. Polli J., Bigora S., Piscitelli D., Straughn A., Young D. Pavlovian food effect on the enterohepatic recirculation of piroxicam. Biopharm. Drug Dispos. 17:1996;635-641
19. Reuter B., Davies N., Wallace J. Nonsteroidal anti-inflammatory drug enterohepathy in rats: role of permeability, bacteria and enterohepatic circulation. Gastroenterology. 112:1997;109-117
20. Rubin S.I., Papich M.G. Clinical uses of nonsteroidal anti-inflammatory drugs in companion animal practice. Part II. Drugs, therapeutic uses and adverse effects. Canine Pract. 15:1990;27-33
21. Schwartz J.B., Nguyen N.H., Schnaare R.L. Compaction studies on beads: compression and consolidation parameters. Drug Dev. Ind. Pharm. 20:1994;3105-3129
22. Vergote G.J., Kiekens F., Vervaet C., Remon J.P. Wax beads as cushioning agents during the compression of coated diltiazem pellets. Eur. J. Pharm. Sci. 17:2002;145-151
23. Wagner K.G., Krumme M., Schmidt P.C. Investigation of the pellet-distribution in single tablets via image analysis. Eur. J. Pharm. Biopharm. 47:1999;79-85
24. Wagner K.G., Krumme M., Schmidt P.C. Pellet-containing tablets. Examination of distribution and deformation behaviour. S.T.P. Pharm. Sci. 10:2000;327-334
25. Zimm K.R., Schwartz J.B., O'Connor R.E. Drug release from a multiparticulate pellet system. Pharm. Dev. Technol. 1:1996;37-42